Posted On: October 4, 2023
Stock Report: SAKAR(NSE) 03 Oct 2023
Industry: Drug Manufacturers – Specialty & Generic
Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offer its products to Srilanka, Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El-salvador, and Paraguay.
#xCalData predicts that # SAKAR will continue its bearish phase over the next five days and trend within the range of 327 to 357.
In comparison to the previous month, the price of the stock has experienced a decline of 7.25% indicating a bearish.
The Stock has doubled twice since 11 Jun 2019 and took an average of 1.1 years to double. .
The stock has shown seasonality trend in the past.
Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 1 years in the past.
Majority of the technical ratios trend towards Bearish side of the spectrum. Only some of the technical indicators namely RSI indicate Bullish view.
Collectively, xCalData suggests the stock would be in Bearish zone for next 5 days.
#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market. Download the app from google play.
For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData